Starting to get a little stir crazy so it’s time for the unpopular opinions game. Gimme a topic, I’ll give you an opinion.
-
-
computing binding affinities of proteins and small molecules has a.) a 50-year history of abject failure; b.) is easily tested experimentally; c.) is sparse as hell so maybe you don't need ML as much; d.) mOsT aPpRoVeD dRuGs dOn'T hAvE tHeIr pUtAtIvE mEcHaNiSmS oF aCtIon
-
Seeing all these coronavirus drug repurposing screening papers with notes that they don't even know whether the drug-protein interaction will inhibit the target protein or enhance the stability of its interactions.
- 2 more replies
New conversation -
-
-
this seems plausible for, say, antibody design, but less so for vaccines how are you envisioning this would work?
-
I was thinking like cancer vaccines where you have a tumor cell culture? could be wrong though
- 9 more replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.